Comparison of Therapeutic Effect and Adverse Effects of Gatifloxacin and Levofloxacin in the Treatment of Bacterial Conjunctivitis

2021 ◽  
1979 ◽  
Vol 17 (14) ◽  
pp. 53-54

Dithranol is a valuable agent in the treatment of chronic discoid psoriasis. Properly used it can clear the lesions in most patients without any of the adverse effects of the strong topical corticosteroids.1 Dithranol inactivates various enzymes, binds with DNA, and inhibits mitosis, but the basis for the therapeutic effect is not fully understood.2 The main drawbacks of dithranol preparations, which often make patients reluctant to treat themselves, are dose-related irritancy, especially affecting normal skin, and staining of skin, clothing and bedclothes. To reduce the spread to normal skin, dithranol is usually applied accurately to psoriatic plaques in a stiff base (Zinc and Salicylic Acid Paste BPC). The salicylic acid in this preparation appears to prevent oxidation of the dithranol to an inactive compound.2


Author(s):  
Roy Gaurab ◽  
Shetti Dattatrya ◽  
Yadav Amit ◽  
Kundu Gopal C

Nanomedicine, an offshoot of nanotechnology, is considered as one of the most promising technologies of the 21st century. Due to their minute size, nanomedicines can easily target difficult-to-reach sites with improved solubility and bioavailability and reduced adverse effects. They also act as versatile delivery systems, carrying both chemotherapeutics and imaging agents to targeted sites. Hence, nanomedicine can be used to achieve the same therapeutic effect at smaller doses than their conventional counterparts and can offer impressive resolutions for various life-threatening diseases. Although certain issues have been raised about the potential toxicities of nanomaterials, it is anticipated that the advances in nanomedicine will furnish clarifications to many of modern medicine's unsolved problems. This chapter aims to provide a comprehensive and contemporary survey of various nanomedicine products along with the major risks and side effects associated with the nanoparticles.


PEDIATRICS ◽  
1971 ◽  
Vol 48 (4) ◽  
pp. 642-646
Author(s):  
William E. Pierson ◽  
C. Warren Bierman ◽  
Stanley J. Stamm ◽  
Paul P. VanArsdel

Significant improvement in ventilatory function without observable adverse effects has been demonstrated by this double-blind controlled trial of intravenous aminophylline in status asthmaticus. Aminophylline appears to have a beneficial therapeutic effect when given in addition to other accepted medications in appropriate dosage and under careful medical supervision to hospitalized children with status asthmaticus.


1977 ◽  
Vol 5 (1) ◽  
pp. 26-32 ◽  
Author(s):  
Louis F Fabre ◽  
Allison Gainey ◽  
Sherrie Kemple

Twenty out-patients suffering from anxiety and tension after withdrawal from alcohol were treated for 28 days with alprazolam. Three patients dropped out for intercurrent events, and 2 dropped out for recurrent drinking. Of the 15 patients completing the study, analysis of variance showed significant improvement in all Physician's Ratings as well as all patient self-ratings. At the 28th day, 93% of the patients rated moderate to marked improvement on the Physician's Global Impression and Therapeutic Effect, and 93% self rated at least a little better. Side-effects were generally mild and inconsequential. No adverse effects attributable to alprazolam were noted on laboratory evaluations, EKG's, or ophthalmologic examinations.


2017 ◽  
pp. 1258-1285
Author(s):  
Roy Gaurab ◽  
Shetti Dattatrya ◽  
Yadav Amit ◽  
Kundu Gopal C

Nanomedicine, an offshoot of nanotechnology, is considered as one of the most promising technologies of the 21st century. Due to their minute size, nanomedicines can easily target difficult-to-reach sites with improved solubility and bioavailability and reduced adverse effects. They also act as versatile delivery systems, carrying both chemotherapeutics and imaging agents to targeted sites. Hence, nanomedicine can be used to achieve the same therapeutic effect at smaller doses than their conventional counterparts and can offer impressive resolutions for various life-threatening diseases. Although certain issues have been raised about the potential toxicities of nanomaterials, it is anticipated that the advances in nanomedicine will furnish clarifications to many of modern medicine's unsolved problems. This chapter aims to provide a comprehensive and contemporary survey of various nanomedicine products along with the major risks and side effects associated with the nanoparticles.


2015 ◽  
Vol 3 (6) ◽  
Author(s):  
Aracely Evangelina Chávez-Piña ◽  
Arlette Guadalupe Arroyo-Lira

Pain is a multidimensional sensory experience that is intrinsically unpleasant and associated with hurting and soreness, it is essentially a sensation. Pain has strong, cognitive and emotional components, it is linked to, or described in terms of suffering. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and opioid analgesics are two of the most common types of drugs used for pain management. However, the use of these analgesics is limited by the presence of significant adverse effects. A useful practice is a combination of two agents with the same therapeutic effect wherein each agent is administered to obtain additive, synergistic or subadditive interaction in a fixed ratio. If the combination resulted in addition or synergism, the doses employed by each agent are reduced, then the side effects are absent; this kind of study is named isobolographic analysis. In this review, the authors summarized previous reports of the combination of NSAIDs with opioids and natural products as an alternative in the pain management.


Nanoscale ◽  
2021 ◽  
Author(s):  
Gan-Qing Xia ◽  
Tian-Run Lei ◽  
Teng-Bo Yu ◽  
Pang-Hu Zhou

The injection of liposomes loaded with TNF-α avoids adverse effects and enhances the therapeutic effect of PD-L1 antibody.


2021 ◽  
Vol 11 (5) ◽  
pp. 344-358
Author(s):  
E. S. Bazrova ◽  
G. D. Kaminskiy ◽  
L. Yu. Ilchenko ◽  
A. Маtin ◽  
I. G. Nikitin

The article considers the features of pharmacotherapy of patients with chronic infectious diseases and co-morbidities in conditions of polypharmacy, the principles of drug metabolism, variants of adverse effects and drug-drug interactions, the possibilities of effective drug combinations. The purpose is to substantiate the possibility and emphasize the relevance of the additional search of the creation of the most optimal combinations of drugs for long-term and massive pharmacotherapy, that could be due to a beneficial drug-drug interaction, optimization of the regimen, route of drug administration and multitarget of the therapeutic effect, reduce the pharmacological load while maintaining the effectiveness of the treatment, increase patient adherence to drug therapy.


2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
Kousuke Ohara ◽  
Shinji Oshima ◽  
Nanami Fukuda ◽  
Yumiko Ochiai ◽  
Ayumi Maruyama ◽  
...  

Oseltamivir phosphate (OP) is used to treat influenza virus infections. However, its use may result in central nervous system (CNS) adverse effects. In Japan, OP is used with Kampo formulations to improve clinical effectiveness. We evaluated the potential for using Kampo formulations to reduce CNS adverse effects by quantifying the CNS distribution of oseltamivir and its active metabolite oseltamivir carboxylate (OC) when administered with maoto and kakkonto. We administered lipopolysaccharide (LPS) by intraperitoneal injection to C57BL/6 mice to reduce blood-brain barrier function. Saline, maoto, and kakkonto were administered orally at the same time as LPS. OP was orally administered 4 hours after the last LPS injection and the migration of oseltamivir and OC was examined. Additionally, we examined the brain distribution of OC following intravenous administration. Changes in OC concentrations in the brain suggest that, in comparison to LPS-treated control mice, both Kampo formulations increased plasma levels of OC, thereby enhancing its therapeutic effect. Additionally, our findings suggest kakkonto may not only improve the therapeutic effect of oseltamivir but also reduce the risk of CNS-based adverse effects. Considering these findings, it should be noted that administration of kakkonto during periods of inflammation has led to increased OAT3 expression.


Sign in / Sign up

Export Citation Format

Share Document